CClinicalTrials.gg
Status unknownNCT05193747ANAPEDUpdated Mar 24, 2023

The Depth of Paediatric Anaesthesia: Observational Trial

An observational study in Anesthesia Awareness, sponsored by Brno University Hospital. Status unknown at 1 site in Czechia. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2023-03-24.

Sponsored by Brno University Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
1 Year to 18 Years
Sex
All
01

Study summary

Perioperative measurement of the Depth of anaesthesia is currently recommended part of daily anaesthesia good clinical practice. The optimal depth of anaesthesia measured by Bispectral index could be between 40-60. The lower (over 60) depth of anaesthesia could be associated with accidental intraoperative episodes of awareness and deeper (below 40) anaesthesia could lead to higher adverse events or even haemodynamic instability.

Read the detailed description

The hypothesis of the trial is that during the perioperative period serious fluctuations outside the recommended target depth of anaesthesia could occur. These fluctuations and the cumulative time spent in the shallow (over 60 BIS) or deep (under 40 BIS) could be associated with postoperative complications like emergence delirium (PAED over 10, and PAED over 12- 2 measurement methods), postoperative nausea and vomiting (PONV) and other postoperative complications (respiratory, hemodynamic).

Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion. The patients will be screened for eligibility during the preanaesthesia visit in the anaesthesiology examination room. After the Ethics committee and registration of the study at clinicaltrials.gov, the patients will be enrolled - according to the trial design. There is a presumption that informed consent won't be needed for participation due to observational trial. The anaesthesia induction will be performed either inhalation or intravenous route. After anaesthesia induction BIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention. The incidence of periods outside the recommended anaesthesia depth will be recorded (episode is defined by ≥ 30 seconds interval outside the predefined limits, the end of episode is defined by the return to recommended BIS level). The cumulative time spent outside the recommended BIS levels will be evaluated as the primary outcome measure. The anaesthesiologist's ability to respond to fluctuations defined as YES / NO response, type of intervention and latency of the anaesthesiologist's response to fluctuation will be evaluated. The BIS recording will be terminated at the time the surgical intervention is finished. After surgery/anaesthesia, the patient will be transferred to ICU or post-anaesthesia care unit (PACU), where the incidence of emergence delirium (defined by PEAD score over 10 and over 12 - according to 2 measurement methods) and the incidence of PONV will be recorded. Also, cumulative incidence of overall complication in the postoperative period (desaturation, the need for oxygen therapy, haemodynamic instability, arrhythmias (over 150/min, below 50/min, allergic reactions) will be recorded. In the case of a critical BIS value (≥90, ≤10), blinding will be interrupted due to patient safety and the value will be notified to the anesthesiology team and the event will be recorded as a critical event.

02

Conditions studied

  • Anesthesia Awareness

Keywords

  • Anesthesia
  • Awareness
  • Pediatric
  • Children
03

In context

Intraoperative Awareness

51 studies on the registry are indexed under Intraoperative Awareness; 7 are open to participants now.

This study's planned enrollment of 100 is close to the median of 108 across 26 observational studies indexed under Intraoperative Awareness.

Browse Intraoperative Awareness studies →

Lead sponsor

Brno University Hospital is the lead sponsor of 91 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 18 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion.

Inclusion criteria

  • Age 1 year-19 years
  • Elective general anaesthesia with presumed duration over 60 minutes
  • BIS monitor available

Exclusion criteria

Exclusion Criteria:

  • Outside the age limits
  • Acute surgery
  • Presumed anaesthesia duration below 1 hour
  • Without the possibility of BIS monitoring
  • Patient indicated for sedation and mechanical ventilation after anesthesia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Paediatric patients scheduled for general anesthesia

    Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion

    Other: Anesthesia depth monitoring

Interventions

  • OtherAnesthesia depth monitoring

    BIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention.

06

What researchers measure

Primary outcomes

  1. Cumulative time outside recommended BIS levels

    The cumulative time spent outside the recommended BIS levels will be evaluated

    Time frame: intraoperatively

  2. Periods outside recommended BIS levels

    The incidence of periods outside the recommended anaesthesia depth will be recorded (episode is defined by ≥ 30 seconds interval outside the predefined limits, the end of episode is defined by the return to recommended BIS level).

    Time frame: intraoperatively

Secondary outcomes

  1. Ability to respond

    The anaesthesiologist's ability to respond to fluctuations defined as YES / NO response, type of intervention and latency of the anaesthesiologist's response to fluctuation will be evaluated.

    Time frame: Intraoperatively

  2. Incidence of emergence delirium

    After surgery/anaesthesia, the patient will be transferred to ICU or PACU, where the incidence of emergence delirium (defined by PEAD over 10 and over 12 - 2 measurement methods) and the incidence of PONV will be recorded.

    Time frame: 2 hours postoperatively

  3. Incidence of overall complications

    Cumulative incidence of overall complication in the postoperative period (desaturation, the need for oxygen therapy, haemodynamic instability, arrhythmias (over 150/min, below 50/min, allergic reactions) will be recorded.

    Time frame: 2 hours postoperatively

  4. Delay to respond

    Latency of the anaesthesiologist's response to fluctuation - defined in seconds from the onset of fluctuation to the end of fluctuation = return to the recommended BIS level

    Time frame: Intraoperatively

  5. Incidence of postoperative nausea and vomiting (PONV(

    Incidence of PONV at PACU

    Time frame: 2 hours postoperatively

07

Study locations

1 of 1 sites recruiting
  • Brno University Hospital
    Brno, South Moravian Region 62500, Czechia
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05193747
Lead sponsor
Brno University Hospital
Collaborators
Masaryk University
Responsible party
Petr Štourač, MD (Clinical Professor, Brno University Hospital) — Principal investigator
First posted
Jan 18, 2022
Start date
Jan 14, 2022
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Mar 24, 2023

Study contacts

Jozef Klučka, assoc.prof.MD., Ph.D.
Contact
klucka.jozef@fnbrno.cz
532234696 ext. +420
Tereza Musilová, MD
Contact
musilova.tereza@fnrbno.cz
532234691 ext. +420
Petr Stourac, prof. MD., Ph.D., MBA
study chair · Department of paediatric anaesthesia and intensive care medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion